Xtant Medical Holdings XTNT Tax Credit Carryforward Valuation Allowance
Tax Credit Carryforward Valuation Allowance at other companies
Other financials
Where this comes from
Reported directly by Xtant Medical Holdings in its filing.
Tagged under the XBRL concept us-gaap:DeferredTaxAssetsValuationAllowance.
The official record: Xtant Medical Holdings’s 10-K, filed March 31, 2026, on SEC EDGAR. View the filing →
Ask your AI about Xtant Medical Holdings's tax credit carryforward valuation allowance.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Xtant Medical Holdings's tax credit carryforward valuation allowance?
- Xtant Medical Holdings (XTNT) reported tax credit carryforward valuation allowance of $18.18M in Q4 2025.
- How has Xtant Medical Holdings's tax credit carryforward valuation allowance changed year-over-year?
- Xtant Medical Holdings's tax credit carryforward valuation allowance decreased by 37.2% year-over-year, from $28.95M to $18.18M.
- What is the long-term trend for Xtant Medical Holdings's tax credit carryforward valuation allowance?
- Over 5 years (2020 to 2025), Xtant Medical Holdings's tax credit carryforward valuation allowance has grown at a -0.8% compound annual growth rate (CAGR), from $18.97M to $18.18M.
- What does tax credit carryforward valuation allowance mean?
- This is a contra-asset account that reduces the carrying value of tax credit carryforwards when it is more likely than not that some or all of the credits will not be realized. It reflects management's assessment of the company's ability to generate sufficient future taxable income. A high allowance suggests uncertainty regarding the realization of tax benefits.